Efficacy and safety of AKT inhibitor and anti-androgen therapy in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis
The Royal College of Radiologists Open · 2023
DOI: 10.1016/j.rcro.2023.100008 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Royal College of Radiologists Open, 2023. Verfasst von Tulika Ashok Kumar Nahar und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nahar, T. A. K., Savin, I., Chohan, N., Bantounou, M., & Kumar, N. (2023). Efficacy and safety of AKT inhibitor and anti-androgen therapy in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis. The Royal College of Radiologists Open. https://doi.org/10.1016/j.rcro.2023.100008
Vancouver
Nahar TAK, Savin I, Chohan N, Bantounou M, Kumar N. Efficacy and safety of AKT inhibitor and anti-androgen therapy in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis. The Royal College of Radiologists Open. 2023. doi:10.1016/j.rcro.2023.100008
BibTeX
@article{Nahar2023,
author = {Nahar, Tulika Ashok Kumar and Savin, Isabella and Chohan, Nakul and Bantounou, Maria and Kumar, Niraj},
title = {Efficacy and safety of AKT inhibitor and anti-androgen therapy in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis},
journal = {The Royal College of Radiologists Open},
year = {2023},
doi = {10.1016/j.rcro.2023.100008}
}
EUVIMED